SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Afentra plc (STGAF) trades at a trailing P/E of 5.5, forward P/E of 3.6. Trailing earnings yield is 18.35%, forward earnings yield 27.70%. PEG 0.07 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (5.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.07); earnings yield beats bond yields (18.35%).
- Forward P/E 3.6 (down from trailing 5.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.07 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 18.35% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 27.70% as earnings recover.
Overall SharesGrow Score: 70/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — STGAF
Valuation Multiples
P/E (TTM)5.5
Forward P/E3.6
PEG Ratio0.07
Forward PEG0.07
P/B Ratio0.00
P/S Ratio1.53
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.20
Forward EPS (Est.)$0.30
Book Value / Share$0.00
Revenue / Share$0.71
FCF / Share$0.00
Yields & Fair Value
Earnings Yield18.35%
Forward Earnings Yield27.70%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.07 |
$5.03M |
$-15.95M |
-317% |
| 2016 |
$-0.04 |
$4.82M |
$-8.53M |
-177.1% |
| 2017 |
$-0.04 |
$4.43M |
$-9M |
-203% |
| 2018 |
$-0.01 |
$534K |
$-1.96M |
-366.3% |
| 2019 |
$-0.01 |
$0.00 |
$-1.66M |
- |
| 2020 |
$-0.01 |
$0.00 |
$-2.03M |
- |
| 2021 |
$-0.02 |
$0.00 |
$-4.91M |
- |
| 2022 |
$-0.04 |
$0.00 |
$-8.92M |
- |
| 2023 |
$-0.01 |
$26.39M |
$-2.71M |
-10.3% |
| 2024 |
$0.20 |
$177.08M |
$48.78M |
27.5% |
